Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.

International journal of radiation oncology, biology, physics - 1 Apr 2011

Jaboin Jerry J, Hwang Misun, Lopater Zachary, Chen Heidi, Ray Geoffrey L, Perez Carmen, Cai Qiuyin, Wills Marcia L, Lu Bo

Abstract excerpt

PURPOSE: To evaluate whether selected high-risk matrix metalloproteinase-7 single nucleotide polymorphisms influence clinicopathologic outcomes in patients with early-stage prostate cancer. METHODS AND MATERIALS: Two hundred twelve prostate cancer patients treated with radical prostatectomy were evaluated with a median follow-up of 9.8 years. Genotyping was performed using hybridization with custom-designed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Analysis of Variance

Share to Matrix Metalloproteinase 7

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 20605361
DOI: 10.1016/j.ijrobp.2010.01.013
PMCID: PMC3782412

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.PMID 20605361Read ↗

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.Semantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.Semantic proximity Read ↗

Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.Semantic proximity Read ↗

Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.Semantic proximity Read ↗

Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsSemantic proximity Read ↗

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.Semantic proximity Read ↗

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.Semantic proximity Read ↗

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.Semantic proximity Read ↗

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.